HLA-B27 - ANKYLOSING SPONDYLITIS - ANVISA Registration 82149920065

Access comprehensive regulatory information for HLA-B27 - ANKYLOSING SPONDYLITIS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82149920065 and manufactured by DNA-TECHNOLOGY, RESEARCH & PRODUCTION. The registration is held by GENESTAR INOVAÇÕES E EQUIPAMENTOS MÉDICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including DNA-TECHNOLOGY, RESEARCH & PRODUCTION, EUROIMMUN AG, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
3 Competitors
82149920065
Registration Details
ANVISA Registration Number: 82149920065
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Kit de PCR em Tempo Real para Genotipagem de HLA-B27 (N)
Risk Class II

Registration Details

82149920065

25351036997202462

35489323000175

Company Information

Russia
PT: RÚSSIA (FEDERAÇÃO RUSSA)

Dates and Status

Mar 04, 2024

VIGENTE

09/18/2025 19:00:01